I’ve learnt a good lesson, on bullshit and lies. The market is...

I’ve learnt a good lesson, on bullshit and lies. The market is not interested in a company like Orthocell, if you can’t get products to market you bullshit and lie in a hope a small company like Samson picks up the products.

Competitive risk - For any future approved Orthocell products, they may not be well adopted in a competitive marketplace, which would adversely affect Orthocells value ( share price )

High stock price volatility - This issue is common among small cap bio tech companies with relatively low trading volumes ( a share price in free fall )

Silence is the biggest killer of a small cap company